CONMED Corp — Director's Dealing 2021

Jul 9, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: CONMED Corp (CNMD)
CIK: 0000816956
Period of Report: 2021-07-01

Reporting Person: Peterson Jaclyn (VP of Mfg. & Adv. Engineering)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Options To Purchase Common Stock	$143.24	2031-05-10	Common Stock (14000)		Direct
Rsus (restricted Stock Units)	$0	2031-05-10	Common Stock (2000)		Direct

Footnotes

F1: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period

F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period.